RECRUITINGINTERVENTIONAL

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

About This Trial

The overall aim of the study is to evaluate the feasibility, acceptability and preliminary effects of the next iteration of iCareBreast+, an innovative breast care e-support intervention programme, by refining existing contents and building new contents based on comprehensive assessment of breast cancer women's needs and preferences among breast cancer patients undergoing chemotherapy. The specific objectives of this study are: 1. To develop a new iteration of an innovative smartphone-based self-care solution for patients with breast cancer undergoing chemotherapy (iCareBreast+); 2. To assess the feasibility and acceptability of iCareBreast+; and 3. To explore the preliminary effects of iCareBreast+ on the primary outcome of self-efficacy, and knowledge of breast cancer treatment, as well as secondary outcomes including anxiety, depression, health-related quality of life (HRQoL), social support and satisfaction with oncologic care.

Who May Be Eligible (Plain English)

Who May Qualify: Women who: - are the age of 21 years old and above at the point of recruitment; - are diagnosed with stage 1-3 breast cancer; - will undergo chemotherapy first time (initiating or up to #4 cycles of chemo is acceptable); - can speak, read and write in English or Mandarin; and - has access to and able to use smart phone. Who Should NOT Join This Trial: Those who : - are with a history of or concurrent other cancer types; - have been suffering from psychiatric illness (e.g., schizophrenia), anxiety disorder or other mood disorder or impaired cognitive function; - have alcohol or substance abuse within the previous year; - are undergoing concurrent psychosocial interventions; and - have been in the bereavement period in the last 6 months - are in their pregnancy. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: Women who: * are the age of 21 years old and above at the point of recruitment; * are diagnosed with stage 1-3 breast cancer; * will undergo chemotherapy first time (initiating or up to #4 cycles of chemo is acceptable); * can speak, read and write in English or Mandarin; and * has access to and able to use smart phone. Exclusion Criteria: Those who : * are with a history of or concurrent other cancer types; * have been suffering from psychiatric illness (e.g., schizophrenia), anxiety disorder or other mood disorder or impaired cognitive function; * have alcohol or substance abuse within the previous year; * are undergoing concurrent psychosocial interventions; and * have been in the bereavement period in the last 6 months * are in their pregnancy.

Treatments Being Tested

OTHER

Routine care

Routine care provided by NCCS

OTHER

Routine care + iCareBreast+ mobile app

Routine care provided by NCCS (identical to the control group) along with access to the iCareBreast+ mobile app

Locations (1)

National Cancer Centre, Singapore

Singapore, Singapore